Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1U72
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,997
Award facts
- Contract value 100% obligated
- $21,997.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,997.34 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 13, 2026, with a completion date of January 14, 2026. This firm fixed-price contract procures Dupixent 300 mg/2 mL pen injections and was awarded without a set-aside designation through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc. (doing business as AmerisourceBergen), which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the vehicle for this pharmaceutical supply order.
AmerisourceBergen is a major pharmaceutical distributor providing critical medical supply chain support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The Dupixent procurement supports military healthcare programs' need for specialty medications, in this case a biologic treatment for allergic and inflammatory conditions. As a non-set-aside competitive award, this order reflects AmerisourceBergen's demonstrated capability to efficiently fulfill federal pharmaceutical requirements across multiple therapeutic domains. The company's extensive portfolio of federal contracts, ranging from small transactions to large-value orders, underscores its role as a key vendor in the Defense Logistics Agency's global pharmaceutical support operations.
Quick answers
Who was awarded contract SPE2DR26F1U72?
SPE2DR26F1U72 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F1U72 worth?
The government has obligated $21,997 on SPE2DR26F1U72.
Is contract SPE2DR26F1U72 an order under another contract?
Yes. SPE2DR26F1U72 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1U72 competed?
The extent of competition for SPE2DR26F1U72 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award